Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)

BACKGROUND: A better understanding of the factors that contribute to heterogeneous outcomes and lifetime disease burden in hypertrophic cardiomyopathy (HCM) is critically needed to improve patient management and outcomes. The SHaRe registry (Sarcomeric Human Cardiomyopathy Registry) was established...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circulation
Hlavní autoři: Ho, Carolyn Y., Day, Sharlene M., Ashley, Euan A., Michels, Michelle, Pereira, Alexandre C., Jacoby, Daniel, Cirino, Allison L., Fox, Jonathan C., Lakdawala, Neal K., Ware, James S., Caleshu, Colleen A., Helms, Adam S., Colan, Steven D., Girolami, Francesca, Cecchi, Franco, Seidman, Christine E., Sajeev, Gautam, Signorovitch, James, Green, Eric M., Olivotto, Iacopo
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2018
Témata:
Original Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6170149/
https://ncbi.nlm.nih.gov/pubmed/30297972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.117.033200
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky